Takeda nearing agreement to buy Shire for $60B — 4 insights

Takeda Pharmaceuticals is nearing an agreement to acquire Shire for approximately $60 billion, the Chicago Tribune reports.

Advertisement

Here’s what you should know.

1. People with knowledge of the matter said the companies are attempting to reach a tentative agreement on price, with a potential announcement as soon as May 1.

2. In accordance with U.K. takeover rules, Takeda must announce a preliminary agreement by May 2 or it’ll have to abandon the bid.

3. Sources told the Tribune the companies are seeking a possible extension.

4. Talks are still progressing and are fluid. The final figure may vary drastically from the rumored $60 billion.

More articles on supply chain:
125k procedures in 30 years: HCA’s Surgery Center of Rome celebrates anniversary
Gateway Ambulatory Surgery Center secures $87k equity financing
Compass Surgical Partners, Martin Health open GI ASC: 4 key points

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.